Indoco Remedies sells Mulgaon land plot to Kalpataru for ₹64 crore
- Indoco Remedies sold a land plot in Mulgaon, Mumbai, to Kalpataru Townships Private Limited
- The transaction value is ₹64 crore for approximately 2,876 square meters of built-up area
- The Deed of Conveyance was executed on August 27, 2026
- The company stated the sale will not impact its business operations
*this image is generated using AI for illustrative purposes only.
Indoco Remedies has executed the Deed of Conveyance for the sale of its land plot in Mulgaon, Mumbai, to Kalpataru Townships Private Limited for ₹64 crore.
Transaction details
The company disclosed the completion of the sale on August 27, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Parameter | Details |
|---|---|
| Asset | Land plot at Plot No.18/A, Mahal Industrial Estate, Village Mulgaon |
| Built-up area | Approximately 2,876.08 square meters |
| Buyer | Kalpataru Townships Private Limited |
| Deal value | ₹64 crore |
| Transaction type | Sale (Deed of Conveyance executed) |
| Date of execution | August 27, 2026 |
The agreement marks a notable asset monetisation development for the pharmaceutical company. Indoco stated that the sale would not have any impact on its business operations and does not constitute an undertaking or substantially the whole of the undertaking under Section 180(1)(a) of the Companies Act, 2013.
No shareholding exists between Indoco and Kalpataru Townships, and the transaction is not classified as a related-party deal. The company confirmed no potential conflict of interest arises from the agreement.
Historical Stock Returns for Indoco Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.50% | +11.67% | -0.37% | +18.75% | -12.52% | -45.86% |
How does Indoco Remedies plan to deploy the ₹64 crore proceeds from the land sale to enhance shareholder value or reduce debt?
What impact will this asset monetization have on Indoco's balance sheet strength and future credit ratings?
Does this sale signal a broader strategy for Indoco to divest non-core real estate assets to focus exclusively on pharmaceutical operations?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
